Immunological profile of heterosexual highly HIV-exposed uninfected individuals: Predominant role of CD4 and CD8 T-cell activation

Journal of Infectious Diseases

Volumn 196, Issue 8, 2007, Pages 1191-1201

  Suy, Anna ^a   Castro, Pedro ^a   Nomdedeu, Meritxell ^a   García, Felipe ^a,c   López, Anna ^a   Fumero, Emilio ^a   Gallart, Teresa ^a   Lopalco, Lucia ^b   Coll, Oriol ^a   Gatell, José M ^a   Plana, Montserrat ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; HLA DR ANTIGEN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HETEROSEXUALITY; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION SENSITIVITY; LYMPHOCYTE FUNCTION; MALE; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PROSPECTIVE STUDY; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENOTYPE; HETEROSEXUALITY; HIV; HIV INFECTIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEXUAL PARTNERS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 35348894949     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/521193     Document Type: Article

References (39)

1. Rowland-Jones S, Sutton J, Ariyoshi K, et al. HIV-specific cytotoxic Tcells in HIV-exposed but uninfected Gambian women. Nature Medicine 1995; 1:59-64.
2. Messele T, Rinke de Wit TF, Brouwer M, et al. No difference in in vitro susceptibility to HIV type 1 between high-risk HIV-negative Ethiopian commercial sex workers and low-risk control subjects. AIDS Res Hum Retroviruses 2001; 17:433-41.
3. Promadej N, Costello C, Wernett MM, et al. Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner. J Infect Dis 2003; 187:1053-63.
4. Mazzoli S, Trabattoni D, Lo CS, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997; 3:1250-7.
5. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-9.
6. Soriano A, Martinez C, Garcia F, et al. Plasma stromal cell-derived factor (SDF)-1 levels, SDF1 - 3′A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression. J Infect Dis 2002; 186:922-31.
7. Kaslow RA, Dorak T, Tang JJ. Influence of host genetic variation on susceptibility to HIV type 1 infection. J Infect Dis 2005; 191(Suppl 1):S68-77.
8. Gonzalez E, Kulkarni H, Bolivar H, et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005; 307:1434-40.
9. Soriano A, Lozano F, Oliva H, et al. Polymorphisms in the interleukin-4 receptor alpha chain gene influence susceptibility to HIV-1 infection and its progression to AIDS. Immunogenetics 2005; 57:644-54.
10. Kebba A, Kaleebu P, Rowland S, et al. Distinct patterns of peripheral HIV-1-specific interferon- g responses in exposed HIV-1-seronegative individuals. J Infect Dis 2004; 189:1705-13.
11. + lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol 2000; 164:1602-11.
12. Makedonas G, Bruneau J, Alary M, et al. Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally. AIDS 2005; 19:251-9.
13. Lopalco L, Barassi C, Pastori C, et al. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro. J Immunol 2000; 164:3426-33.
14. Barassi C, Lazzarin A, Lopalco L. CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects. Blood 2004; 104:2205-6.
15. Lo CS, Trabattoni D, Vichi F, et al. Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men. AIDS 2003; 17:531-9.
16. Eyeson J, King D, Boaz MJ, et al. Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects. AIDS 2003; 17:2299-311.
17. Hladik F, Desbien A, Lang J, et al. Most highly exposed seronegative men lack HIV-1-specific, IFN-g-secreting T cells. J Immunol 2003; 171:2671-83.
18. Koning FA, Jansen CA, Dekker J, et al. Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual behavior. AIDS 2004; 18:1117-26.
19. Biasin M, Caputo SL, Speciale L, et al. Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women. J Infect Dis 2000; 182:1365-74.
20. Jennes W, Sawadogo S, Koblavi-Deme S, et al. Cellular human immunodeficiency virus (HIV)-protective factors: a comparison of HIV-exposed seronegative female sex workers and female blood donors in Abidjan, Côte d'Ivoire. J Infect Dis 2003; 187:206-14.
21. Killian MS, Monteiro J, Matud J, et al. Persistent alterations in the Tcell repertoires of HIV-1-infected and at-risk uninfected men. AIDS 2004; 18:161-70.
22. Tran HK, Chartier L, Troung LX, et al. Systemic immune activation in HIV-1-exposed uninfected Vietnamese intravascular drug users. AIDS Res Hum Retroviruses 2006; 22:255-61.
23. Yang OO, Boscardin WJ, Matud J, et al. Immunologic profile of highly exposed yet HIV type 1-seronegative men. AIDS Res Hum Retroviruses 2002; 18:1051-65.
24. + T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol 2005; 175:6117-22.
25. Begaud E, Chartier L, Marechal V, et al. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 2006; 3:35-44.
26. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996; 273:1856-62.
27. Libois A, Lopez A, Garcia F, et al. Dynamics of T cells subsets and lymphoproliferative responses during structured treatment interruption cycles and after definitive interruption of HAART in early chronic HIV type-1-infected patients. AIDS Res Hum Retroviruses 2006; 22:657-66.
28. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med 1999; 5:518-25.
29. García F, Plana M, Arnedo M, et al. A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions. A randomized study. AIDS 2003; 17:43-51.
30. Clerici M, Barassi C, Devito C, et al. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41. AIDS 2002; 16:1731-41.
31. Lopalco L, Barassi C, Paolucci C, et al. Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin. J Gen Virol 2005; 86:339-48.
32. Barabas E, Kemeny B, Gonzalez R, Varkonyi V, Nagy K, Horvath A. A comparison of the lymphoproliferative capacity of pokeweed mitogen (PWM) and phytohaemagglutinin (PHA) in CCR-5 wild-type and heterozygous HIV-infected and uninfected subjects. Int J STD AIDS 2002; 13:691-7.
33. de la Calle-Martin O, Alberola J, Engel P, et al. Impaired post-transcriptional expression of interleukin-2 receptor in pokeweed mitogen-activated T cells. Eur J Immunol 1992; 22:897-902.
34. Ioannidis JP, Rosenberg PS, Goedert JJ, et al. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3′A alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data. Ann Intern Med 2001; 135:782-95.
35. Philpott S, Weiser B, Tarwater P, et al. CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women. J Infect Dis 2003; 187:569-75.
36. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996; 2: 1240-3.
37. Hladik F, Liu H, Speelmon E, et al. Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission. J Virol 2005; 79:11677-84.
38. + T cells during peripheral differentiation. Eur J Immunol 2004; 34:3370-8.
39. Patterson BK, Czerniewski M, Andersson J, et al. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes. Clin Immunol 1999; 91:254-62.